Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein ProtectIn Vivovia Fcγ Receptor and Complement-Dependent Effector Mechanisms
- 15 November 2011
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (22), 11567-11580
- https://doi.org/10.1128/jvi.05859-11
Abstract
The human antibody response to flavivirus infection is dominantly directed against a cross-reactive epitope on the fusion loop of domain II (DII-FL) of the envelope (E) protein. Although antibodies against this epitope fail to recognize fully mature West Nile virus (WNV) virions and accordingly neutralize infection poorly in vitro, their functional properties in vivo remain less well understood. Here, we show that while passive transfer of poorly neutralizing monoclonal antibodies (MAb) and polyclonal antibodies against the DII-FL epitope protect against lethal WNV infection in wild-type mice, they fail to protect mice lacking activating Fcγ receptors (FcγR) and the complement opsonin C1q. Consistent with this, an aglycosyl chimeric mouse-human DII-FL MAb (E28) variant that lacks the ability to engage FcγR and C1q also did not protect against WNV infection in wild-type mice. Using a series of immunodeficient mice and antibody depletions of individual immune cell populations, we demonstrate that the nonneutralizing DII-FL MAb E28 does not require T, B, or NK cells, inflammatory monocytes, or neutrophils for protection. Rather, E28 treatment decreased viral load in the serum early in the course of infection, which resulted in blunted dissemination to the brain, an effect that required phagocytic cells, C1q, and FcγRIII (CD16). Overall, these studies enhance our understanding of the functional significance of immunodominant, poorly neutralizing antibodies in the polyclonal human anti-flavivirus response and highlight the limitations of current in vitro surrogate markers of protection, such as cell-based neutralization assays, which cannot account for the beneficial effects conferred by these antibodies.Keywords
This publication has 94 references indexed in Scilit:
- Direct Complement Restriction of Flavivirus Infection Requires Glycan Recognition by Mannose-Binding LectinCell Host & Microbe, 2010
- Key role of T cell defects in age-related vulnerability to West Nile virusThe Journal of Experimental Medicine, 2009
- Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile VirusCell Host & Microbe, 2009
- Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanismVirology, 2009
- Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibodyThe EMBO Journal, 2009
- Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile VirusThe Journal of Infectious Diseases, 2009
- Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine developmentCell Host & Microbe, 2008
- Molecular mechanisms of antibody-mediated neutralisation of flavivirus infectionExpert Reviews in Molecular Medicine, 2008
- The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus InfectionCell Host & Microbe, 2007
- Protective immune responses against West Nile virus are primed by distinct complement activation pathwaysThe Journal of Experimental Medicine, 2006